Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
Sodium Hydroxide → 1-Methyl-4-[3-(4-nitrophenyl)-4-oxo-4-piperidin-1-ylbutanoyl]piperazine
참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|---|---|---|
| 반응물 | Sodium Hydroxide | HCID 14798 | — |
| 반응물 | 1-Methylpiperazine | HCID 53167 | — |
| 반응물 | Methyl bromoacetate | HCID 60984 | — |
| 반응물 | 1-[(4-Nitrophenyl)acetyl]piperidine | HCID 3594276 | — |
| 용매 | Methanol | HCID 887 | — |
| 생성물 | 1-Methyl-4-[3-(4-nitrophenyl)-4-oxo-4-piperidin-1-ylbutanoyl]piperazine | HCID 67388518 | — |
반응 단계
1-[(4-Nitrophenyl)acetyl]piperidine was alkylated with methyl -bromoacetate in the same manner as in Reference Example 47, hydrolyzed with 1 M sodium hydroxide aqueous solution in methanol, and then condensed with 1-methylpiperazine in the same manner as in Reference Example 5 to obtain 1-methyl-4-[3-(4-nitrophenyl)-4-oxo-4-piperidin-1-ylbutanoyl]piperazine (ESI: 389). This piperazine compound was subjected to the reduction of nitro group in the same manner as the catalytic hydrogenation shown in Reference Example 3 and then treated with lithium aluminum hydride to obtain 4-[3-(4-methylpiperazin-1-yl)-1-(piperidin-1-ylmethyl)propyl]aniline. ESI: 331.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|---|
| 특허 번호 | US07449456B2 |
| 출처 데이터셋 | uspto-grants-2008_11 |
| ORD ID | ord-aa9c27791de64b749e28758bedf6fb33 |
| 출처 메모 | uspto-grants-2008_11 |